Skip to main content

Table 4 Explanatory factors related to antibiotic use (number of discharges as denominator) in 22 Norwegian Health Enterprises, 2006–2011, derived from six multiple linear regression models

From: Hospital- and patient-related factors associated with differences in hospital antibiotic use: analysis of national surveillance results

Independent variables

WHO DDDs/100 discharges

Hospital-adjusted DDDs/100 discharges

All antibiotics

Broad-spectruma

All penicillinsb

All antibiotics

Broad-spectruma

All penicillinsb

Overall model, R 2 (adjusted R 2 )

0.71 (0.67)

0.30 (0.22)

0.68 (0.65)

0.71 (0.68)

0.34 (0.26)

0.72 (0.69)

Infect. disease ICD-10 main diag. (%)

Regression coeff. (95% confidence interval (C.I.))

30.6*** (15.9; 45.2)

 

21.9*** (10.0; 33.8)

16.4*** (7.5; 25.4)

 

8.95*** (4.3; 13.6)

Beta weight

0.44

 

0.45

0.36

 

0.44

Increment in R2

0.0588

 

0.0614

0.0406

 

0.0591

Registered nurses per 100 beds

Regression coeff. (95% C.I.)

0.78*** (0.37; 1.20)

 

0.46*** (0.21; 0.72)

0.49*** (0.21; 0.77)

 

0.17** (0.07; 0.27)

Beta weight

0.43

 

0.36

0.42

 

0.43

Increment in R2

0.0657

 

0.0463

0.0625

 

0.0357

Hospital stay > 10 days (%)

Regression coeff. (95% (C.I.)

12.1** (5.1; 19.2)

2.38** (0.9; 3.86)

7.46* (1.2; 13.7)

8.27*** (4.4; 12.2)

2.75** (1.2; 4.3)

2.99*** (0.4; 5.6)

Beta weight

0.48

0.45

0.42

0.51

0.56

0.41

Increment in R2

0.0861

0.0753

0.0663

0.0956

0.1157

0.0616

University hospital (binary)

Regression coeff. (95% C.I.)

−47.6*** (−84.6; −10.7)

−9.8** (−15.5; −4.1)

 

−33.6*** (−51.1; −16.2)

−10.9*** (−14.5; −7.2)

 

Beta weight

−0.36

−0.35

 

−0.39

−0.42

 

Increment in R2

0.0458

0.0441

 

0.0545

0.0626

 

Surgical DRGs c per 100 beds

Regression coeff. (95% C.I.)

   

2.43* (0.2; 4.6)

  

Beta weight

   

0.35

  

Increment in R2

   

0.0316

  
  1. Significance levels: *P < 0.05, **P < 0.01, ***P < 0.001.
  2. aBroad-spectrum antibiotics: second- and third-generation cephalosporins, fluoroquinolones, carbapenems, and penicillins with enzyme inhibitors.
  3. bAll penicillins: penicillinase sensitive, penicillinase resistant and extended-spectrum penicillins.
  4. cDRG: Diagnosis-related groups.